Emerging ciprofloxacin-resistant Pseudomonas aeruginosa
Related Experiment Video
Updated: Oct 18, 2026

Replication of the Ordered, Nonredundant Library of Pseudomonas aeruginosa strain PA14 Transposon Insertion Mutants
Published on: May 4, 2018
N A Chaudhry1, H W Flynn, T G Murray
1Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami School of Medicine, Florida 33136, USA.
Purpose:
To report a clinical series of ciprofloxacin-resistant ocular isolates of Pseudomonas aeruginosa from a tertiary care ophthalmic center.
Methods:
Review of in vitro sensitivities of all ocular isolates of P. aeruginosa be tween July 1991 and September 1998. In vitro resistance was defined as a minimum inhibitory concentration of 4 or more microg per ml.
Results:
Nine of 423 ocular isolates of P. aeruginosa showed in vitro resistance to ciprofloxacin. From 1991 to 1994, 0.44% (1/227) of ocular isolates were resistant to ciprofloxacin, whereas from 1995 to 1998, 4.1% (8/ 196) of ocular isolates showed in vitro resistance (P = .014).
Conclusions:
Ciprofloxacin-resistant P. aeruginosa has been identified in recent clinical ocular specimens. Ciprofloxacin resistance among ocular isolates of P. aeruginosa is a local and worldwide concern.
Insights
Ciprofloxacin resistance in ocular Pseudomonas aeruginosa is increasing. This study identified a significant rise in resistant strains between 1995-1998 compared to earlier years, highlighting a growing clinical concern.
Area of Science:
- Ophthalmology
- Microbiology
- Infectious Diseases
Background:
- Pseudomonas aeruginosa is a common cause of ocular infections.
- Ciprofloxacin is a frequently used antibiotic for bacterial eye infections.
- Emergence of antibiotic resistance is a significant challenge in clinical practice.
Purpose of the Study:
- To document the prevalence of ciprofloxacin-resistant ocular isolates of Pseudomonas aeruginosa.
- To analyze trends in ciprofloxacin resistance over time.
- To assess the clinical significance of this resistance pattern.
Main Methods:
- Retrospective review of ocular Pseudomonas aeruginosa isolates from July 1991 to September 1998.
- In vitro susceptibility testing to determine minimum inhibitory concentrations (MICs).
- Resistance defined as MIC ≥ 4 µg/mL.
Main Results:
- Nine out of 423 (2.1%) ocular isolates of P. aeruginosa were resistant to ciprofloxacin.
- A significant increase in resistance was observed from 0.44% (1991-1994) to 4.1% (1995-1998) (P = .014).
- This indicates a growing trend of ciprofloxacin resistance.
Conclusions:
- Ciprofloxacin-resistant Pseudomonas aeruginosa has emerged in clinical ocular specimens.
- This resistance poses a growing local and global public health concern.
- Continued surveillance and management strategies are necessary.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Inhibitors of Bacterial DNA Synthesis
Development of Antibiotic Resistance
Gene Regulation in Microbial Communities: Quorum Sensing
